Part 2: An Expert Approach to Cardiorenal Protection in CKD

This two-part program, produced in collaboration with Radcliffe Cardiology, considers the guideline-directed approach to chronic kidney disease (CKD) and how SGLT-2 inhibitors can be used to maximal effect. The webinars are chaired by Professor James Burton, MD (University of Leicester, United Kingdom), with expert insight from world-renowned faculty Professor David Wheeler, MD (University College London, UK), Professor Navdeep Tangri, MD (University of Manitoba, Canada), and Professor Carol Pollock, MD (University of Sydney, Australia).
Part 2 of this dynamic series offers a forensic analysis of current practices, revisiting the patient case from Part 1 in reflection of expected guideline updates. The panel provides evidence-based strategies for initiating pharmacological therapies that transcend the theoretical and become actionable in everyday practice.

[@ShimmyMD]

Dr Tangri is an excellent teacher. I’m glad you were part of this panel.

[@hamadaadl5637]

Thanks

[@ShimmyMD]

Dr Tangri - one comment (constructive criticism if I may)
I looked at the guidelines and they make a note that nuclear imaging is not as reliable as something like iohexol. Maybe I’m missing something?